These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 8203835)

  • 1. In vivo activities and penetration of the two components of the streptogramin RP 59500 in cardiac vegetations of experimental endocarditis.
    Fantin B; Leclercq R; Ottaviani M; Vallois JM; Maziere B; Duval J; Pocidalo JJ; Carbon C
    Antimicrob Agents Chemother; 1994 Mar; 38(3):432-7. PubMed ID: 8203835
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of experimental endocarditis due to erythromycin-susceptible or -resistant methicillin-resistant Staphylococcus aureus with RP 59500.
    Entenza JM; Drugeon H; Glauser MP; Moreillon P
    Antimicrob Agents Chemother; 1995 Jul; 39(7):1419-24. PubMed ID: 7492078
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of levofloxacin for experimental aortic-valve endocarditis in rabbits infected with viridans group streptococcus or Staphylococcus aureus.
    Chambers HF; Xiang Q; Liu ; Chow LL; Hackbarth C
    Antimicrob Agents Chemother; 1999 Nov; 43(11):2742-6. PubMed ID: 10543757
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Studies of RP 59500 in vitro and in a rabbit model of aortic valve endocarditis caused by methicillin-resistant Staphylococcus aureus.
    Chambers HF
    J Antimicrob Chemother; 1992 Jul; 30 Suppl A():117-22. PubMed ID: 1399943
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Critical influence of resistance to streptogramin B-type antibiotics on activity of RP 59500 (quinupristin-dalfopristin) in experimental endocarditis due to Staphylococcus aureus.
    Fantin B; Leclercq R; Merlé Y; Saint-Julien L; Veyrat C; Duval J; Carbon C
    Antimicrob Agents Chemother; 1995 Feb; 39(2):400-5. PubMed ID: 7726505
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of Telavancin in a rabbit model of aortic valve endocarditis due to methicillin-resistant Staphylococcus aureus or vancomycin-intermediate Staphylococcus aureus.
    Madrigal AG; Basuino L; Chambers HF
    Antimicrob Agents Chemother; 2005 Aug; 49(8):3163-5. PubMed ID: 16048918
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antistaphylococcal activities of quinupristin/dalfopristin in vitro across platelet-fibrin matrices and in experimental endocarditis.
    Berthaud N; Huet Y; Diallo N; Desnottes JF
    J Antimicrob Chemother; 1997 May; 39 Suppl A():93-8. PubMed ID: 9511071
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacies of quinupristin-dalfopristin combined with vancomycin in vitro and in experimental endocarditis due to methicillin-resistant Staphylococcus aureus in relation to cross-resistance to macrolides, lincosamides, and streptogramin B- type antibiotics.
    Pavie J; Lefort A; Zarrouk V; Chau F; Garry L; Leclercq R; Fantin B
    Antimicrob Agents Chemother; 2002 Sep; 46(9):3061-4. PubMed ID: 12183272
    [TBL] [Abstract][Full Text] [Related]  

  • 9. RP 59500 prophylaxis of experimental endocarditis due to erythromycin-susceptible and -resistant isogenic pairs of viridans group streptococci.
    L'Hériteau F; Entenza JM; Lacassin F; Leport C; Glauser MP; Moreillon P
    Antimicrob Agents Chemother; 1995 Jul; 39(7):1425-9. PubMed ID: 7492079
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of resistance to streptogramin A type antibiotics on the activity of quinupristin-dalfopristin in vitro and in experimental endocarditis due to Staphylococcus aureus.
    Zarrouk V; Bozdogan B; Leclercq R; Garry L; Carbon C; Fantin B
    Antimicrob Agents Chemother; 2000 May; 44(5):1168-73. PubMed ID: 10770747
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Treatment with vancomycin of experimental endocarditis caused by Streptococcus sanguis II resistant to penicillin].
    Martínez F; Martín Luengo F; Valdés M
    Enferm Infecc Microbiol Clin; 1993 May; 11(5):255-9. PubMed ID: 8324022
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Endocarditis due to methicillin-resistant Staphylococcus aureus in rabbits: expression of resistance to beta-lactam antibiotics in vivo and in vitro.
    Chambers HF; Hackbarth CJ; Drake TA; Rusnak MG; Sande MA
    J Infect Dis; 1984 Jun; 149(6):894-903. PubMed ID: 6564133
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative activity of cloxacillin and vancomycin against methicillin-susceptible Staphylococcus aureus experimental endocarditis.
    Fernández Guerrero ML; de Górgolas M
    J Antimicrob Chemother; 2006 Nov; 58(5):1066-9. PubMed ID: 16931540
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of temafloxacin in experimental Streptococcus adjacens endocarditis and autoradiographic diffusion pattern of [14C]temafloxacin in cardiac vegetations.
    Cremieux AC; Saleh-Mghir A; Vallois JM; Maziere B; Muffat-Joly M; Devine C; Bouvet A; Pocidalo JJ; Carbon C
    Antimicrob Agents Chemother; 1992 Oct; 36(10):2216-21. PubMed ID: 1332590
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In-vitro and in-vivo synergic activity and fractional inhibitory concentration (FIC) of the components of a semisynthetic streptogramin, RP 59500.
    Bouanchaud DH
    J Antimicrob Chemother; 1992 Jul; 30 Suppl A():95-9. PubMed ID: 1399956
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activities of the combination of quinupristin-dalfopristin with rifampin in vitro and in experimental endocarditis due to Staphylococcus aureus strains with various phenotypes of resistance to macrolide-lincosamide-streptogramin antibiotics.
    Zarrouk V; Bozdogan B; Leclercq R; Garry L; Feger C; Carbon C; Fantin B
    Antimicrob Agents Chemother; 2001 Apr; 45(4):1244-8. PubMed ID: 11257041
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Minocycline versus vancomycin for treatment of experimental endocarditis caused by oxacillin-resistant Staphylococcus aureus.
    Nicolau DP; Freeman CD; Nightingale CH; Coe CJ; Quintiliani R
    Antimicrob Agents Chemother; 1994 Jul; 38(7):1515-8. PubMed ID: 7979281
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment with imipenem of experimental endocarditis caused by penicillin-resistant Streptococcus sanguis.
    Martínez F; Martín-Luengo F; Garcia A; Valdés M
    J Antimicrob Chemother; 1994 Jun; 33(6):1201-7. PubMed ID: 7928813
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quinupristin-dalfopristin combined with beta-lactams for treatment of experimental endocarditis due to Staphylococcus aureus constitutively resistant to macrolide-lincosamide-streptogramin B antibiotics.
    Vouillamoz J; Entenza JM; Féger C; Glauser MP; Moreillon P
    Antimicrob Agents Chemother; 2000 Jul; 44(7):1789-95. PubMed ID: 10858332
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative efficacies of imipenem-cilastatin and vancomycin in experimental aortic valve endocarditis due to methicillin resistant Staphylococcus aureus.
    Chandrasekar PH; Levine DP; Price S; Rybak MJ
    J Antimicrob Chemother; 1988 Apr; 21(4):461-9. PubMed ID: 3378959
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.